Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept in Psoriatic Arthritis and Psoriasis
NCT00317499Phase 3Completed
- Sponsor
- Amgen
- Start
- Apr 2000
- Primary completion
- Jun 2002
- Modality
- Fc-Fusion Proteins
01
Overview
A Phase 3 trial of etanercept in psoriatic arthritis (PsA), psoriasis, sponsored by Amgen. Started Apr 2000; status: completed.
02
Drugs
etanercept
03
Conditions
psoriatic arthritis (PsA)psoriasis
Beyond the preview
Go deeper on NCT00317499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00317499.